Merck Healthcare KGaA, Darmstadt, Germany
Clinical trials sponsored by Merck Healthcare KGaA, Darmstadt, Germany, explained in plain language.
A healthcare division of Merck KGaA, a global science and technology company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced colorectal cancer: targeted drug M9140 enters early trial Results expected Sep 2026 (estimated)
- New drug M5542 tested in humans for first time Results expected Nov 2026 (estimated)